PTX 0.00% 4.4¢ prescient therapeutics limited

Ann: Continued promising results in PTX-100 TCL trial, page-27

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,768 Posts.
    lightbulb Created with Sketch. 4475
    Without a doubt, based on the recent announcements, PTX is definitely the most undervalued research biotech on the ASX. The market cap is still under $100m. Once this gets approval for registrational trial, it would easily 10 bags from here. Might be even more if there is some sort of M&A activity to follow it.

    All in all, best value biotech right now. And with its low SOI, when this moves, it will really move.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.